Markets » Mutual Funds » Asset Allocation

Nippon India Pharma Fund - Direct (Bonus) - Scheme Profile

Fund

Fund House : Nippon India Mutual Fund

Fund Class : Equity - Pharma

NAV 07 Dec 2022 313.43 -1.74
(-0.55%)

Asset Type

Asset Allocation
Cash & Cash Equivalent 0.00
Equity 99.65
Reverse Repo 0.78
Equity Sector No. of Shares Mkt Value % of Assets Stocks Return
Asset / Company Name     (Rs cr)   Last 3 Mths
Sun Pharma.Inds. Pharmaceuticals & Biotechnology 7,000,976 732.34 15.30 9.71
Cipla Pharmaceuticals & Biotechnology 3,700,000 421.67 8.81 4.83
Dr Reddy's Labs Pharmaceuticals & Biotechnology 885,000 397.11 8.30 1.99
Lupin Pharmaceuticals & Biotechnology 4,500,025 344.75 7.20 13.17
Abbott India Pharmaceuticals & Biotechnology 129,321 261.72 5.47 12.25
Apollo Hospitals Healthcare Services 520,772 246.14 5.14 6.6
› More

Sector Allocation

You can check out the sectoral allocation of the investments made for that scheme by the mutual fund in this Piechart as on the date selected.

Sector Name
Healthcare Equipment & Supplies 0.32
Healthcare Services 19.43
NA 0.78
Pharmaceuticals & Biotechnology 79.76
Retailing 0.14

Top Holdings

You can check out the Top Holdings of the investments made for that scheme by the mutual fund in
this Piechart as on the date selected.

Company Name
Abbott India 5.47
Ajanta Pharma 1.85
Alkem Lab 1.84
Apollo Hospitals 5.14
Aurobindo Pharma 3.42
Cipla 8.81
Divi's Lab. 4.62
Dr Reddy's Labs 8.30
.